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Mycoplasma pneumoniae infection in patients with 
Kawasaki disease
Purpose: Kawasaki disease (KD) is the main cause of acquired heart 
disease in children. In addition to cardiovascular involvement, many 
complications have been recognized in KD. However, respiratory com-
plications have been rarely reported. We investigated the differences 
in clinical characteristics, laboratory findings, radiography findings, and 
echocardiography findings of Mycoplasma pneumoniae infection and 
other types of pneumonia in KD patients. 
Methods: Among 358 patients with KD, 54 developed concurrent 
pneumonia. Among the 54 patients, 12 (22.2%) with high titers of 
anti-M. pneumoniae antibody (AMA) (>1:640) were grouped in the M. 
pneumoniae group and 42 were included in the control group. Serum 
AMA was measured in each patient. Clinical laboratory findings and 
total duration of fever were analyzed. 
Results: The duration of fever, serum hemoglobin, white blood cell 
count, platelet count, erythrocyte sedimentation rate, C-reactive 
protein level, albumin level, and the incidence of coronary arterial 
lesions showed no statistical difference in the 2 groups. Neutrophil 
count was significantly higher in the M. pneumoniae group than in 
the control group. Among various radiography findings observed in 
pneumonia, consolidation and pleural effusion were more frequent in 
the M. pneumoniae group than in the control group. On the other hand, 
parahilar peribronchial opacification, diffuse interstitial lesion, and 
normal findings prevailed in the control group.
Conclusion: KD patients can have concurrent infections, especially 
pulmonary symptoms. The cause of KD is likely to be associated with 
M. pneumoniae infection. Thus, immediate treatment of M. pneumoniae 
infection in KD patients is very important.
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Introduction
Kawasaki disease (KD) is an acute, self-limited vasculitis that affects 
mainly infants and young children
1, 2). The major clinical features are 
fever lasting at least 5 days, bilateral conjunctival injection, changes 
of the oral mucosa, erythematous changes of the hands and feet, 
polymorphous skin rashes, and enlarged cervical lymphadenopathy. 
Of the patients with untreated KD, 10-15% develope coronary artery 
lesions and a greater proportion develop coronary arterial dilation
3-5). 
KD is a major cause of acquired heart disease in children. 
The etiology of KD is unclear but superantigens may play a part. 
Despite multiple investigations and many candidates, no unique 
infectious agent has been identified as the sole etiologic agent 
responsible for KD. There is no definite diagnostic test for KD and 
therefore accurate and timely diagnosis of KD is challenging for 
clinicians. Clinicians must rely on the presence of specific clinical 
criteria and laboratory data, excluding other illnesses that can mimic 
the disease
6). Many studies support the existence of an infectious 
trigger for KD including the epidemiology of the disease by seasonal 
fluctuations and the reported temporal relationship to various 
infectious agents
7-9). Previous reports have frequently used a screening 
approach to determine the prevalence of an infectious agent in patients 
with KD.
Many complications other than cardiovascular involvement 
have been recognized in KD. However, there have been few reports 
published concerning the involvement of the lungs in this disease
10-17). 
In this study, we investigated differences in clinical characteristics, 
laboratory findings, X-ray findings and echocardiographic findings 
between Mycoplasma pneumoniae and other types of pneumonia 
developed in KD.
Materials and methods
This study was conducted at Ewha Womans University Hospital, 
Department of Pediatrics, from December 2003 to July 2007. A total 
of 358 patients with KD were admitted to Ewha Womans University 
Hospital and 54 patients of them were found to have pneumonia, 
concurrently. We estimated serum anti-Mycoplasma pneumoniae 
antibody (AMA) titer in patients with KD who had abnormal chest 
X-ray findings. The diagnosis of M. pneumoniae infection was 
confirmed by serologic tests with elevated single titers (>1:640) or a 
fourfold rise in titer. Among the enrolled 54 patients, 12 who had 
high titers of AMA were grouped as M. pneumoniae group, and the 
other 42 as control group. All of the patients received treatment with 
intravenous immunoglobulin (IVIG) (2 g/kg/day for 1 day) and oral 
aspirin (50 mg/kg/day).
Echocardiography was obtained by pediatric cardiologists 
to detect the presence of any coronary artery lesions prior to 
IVIG administration. Coronary aneurysm was diagnosed from 
echocardiogram using the criteria proposed by the Japanese Kawasaki 
Disease Research Committee. Coronary arteries were classified as 
abnormal in the following cases: an internal lumen diameter greater 
than 3 mm in children at the age of 4 or younger and greater than 
4 mm in children at the age of 5 or older; the internal diameter of a 
segment measured 1.5 times larger than that of the adjacent segment; 
or a coronary lumen that is clearly irregular
18). Laboratory data were 
obtained from each child including Hb, white blood cell (WBC ) 
count, platelet count, serum albumin, erythrocyte sedimentation rate 
(ESR) and C-reactive protein level (CRP). The study was carried out 
with the approval of the Ethics Committee of the Ewha Womans 
University Hospital Institutional Review Board, and written informed 
consents were obtained from the parents of all the subjects. Serum 
AMA was measured using particle agglutination test according to the 
manufacturer’s instructions. Clinical characteristics including Hb, 
WBC count, platelet count, serum albumin, ESR, CRP and total 
duration of fever were analyzed each as a quantitative trait. 
Statistical analysis
We performed all statistical analyses using SPSS (version 11.0, SPSS 
Inc, Chicago, IL, USA). Descriptive statistics were presented as means 
and standard deviations. The comparison of continuous variables was 
done using the Student t-test or one-way analysis of variance. A P- 
value less than 0.05 was considered as statistically significant. 
Results
Clinical characteristics of the study groups are shown in Table 1. 
The mean age of the M. pneumoniae group was 5.5±3.5 years and 
that of the control group was 2.8±2.2 years. The M. pneumoniae 
group was significantly older than the control group. There was no 
statistical difference in the date of intravenous immunoglobulin 
(IVIG) infusion or the duration of fever.
We also analyzed echocardiographic findings of each group, which 
are shown in Table 2. The diameter of the right coronary artery was 
Table 1. Characteristics of the Study Groups
 M. pneumoniae group (n=12) Control group(n=42)
Age(year)  5.5±3.5* 2.8±2.2
IVIG (HD) 4.5±3.8 3.1±2.7
DOF(day) 9.2±4.7 6.9±3.9
Abbrevations: IVIG, infusion date of IVIG; HD, hospital day; DOF, duration of 
fever.
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4.9±2.1 mm in the M. pneumoniae group and 3.6±1.2 mm in the 
control group. The diameter of the left coronary artery was 2.8±0.8 
mm and 2.7±0.8 mm, respectively, in the M. pneumoniae group 
and the control group. The echocardiographic findings showed no 
significant difference between these two groups.
Clinical parameters were compared between the M. pneumoniae 
group and the control group. Laboratory findings of each group were 
shown in Table 3. Hb, WBC count, platelet count, ESR, CRP and 
serum albumin were not significantly different between the two 
groups. However, PMN was significantly higher and the lymphocyte 
count was significantly lower in the M. pneumoniae group than in 
the control group. 
We compared chest X-ray findings of each group to find any 
distinguished characteristics. The most common radiographic 
findings were listed in Table 4. Among the chest X-ray findings, 
focal reticulonodular lesion, atelectasis and hilar lymphadenopathy 
were not significantly different between the M. pneumoniae group 
and the control group. The relatively frequent chest X-ray image 
findings in the M. pneumoniae group were consolidation (58.3%, 
Fig. 1), parahilar peribronchial opacification (50%, Fig. 2) and focal 
reticulonodular lesion (41.7%, Fig. 3). In the X-ray findings of the 
M. pneumoniae group, consolidation and pleural effusion were 
prevalent. In contrast, parahilar peribronchial opacification, diffuse 
interstitial and normal findings were prevalent in the control group.
Discussion 
In a recent multicenter study, Leung et al.
19) screened 45 patients 
Table 2. Echocardiography Findings of Kawasaki Disease Patients
Diameter (mm)  M. pneumoniae group (n=12) Control group (n=42)
RCA 4.9±2.1 3.6±1.2
LCA 2.8±0.8 2.7±0.8
Abbrevations: RCA, right coronary artery; LCA, left coronary artery.
Table 3. Laboratory findings of Study Groups
Laboratory findings*  M. pneumoniae group (n=12) Control group (n=42)
Hb (g/dL) 5.5±3.5 2.8±2.2
WBC (mm
3) 10,258.3±5,910.3 11,054.8±5,795.7
PMN (%) 67.1±18.8* 52.3±17.6
Lymphocyte (%) 24.0±16.6* 36.5±16.4
Platelet (±10
3/mm
3 )     335.0±829.0 339.1±152.0
ESR (mm/hr) 44.9±23.2 38.3±32.9
CRP (mg/dL) 8.0±8.8 3.4±4.7
Albumin (g/dL) 3.9±0.6 4.1±0.4
*Data for each group are expressed as mean±standard deviation.
The significance of clinical parameters according to groups was analyzed 
using the Mann-Whitney test.  
Abbrevations: CBC, complete blood cell count; ESR, erythrocyte sendi-
mentation rate; CRP, C-reactive protein; PMN, polymorphonuclear cell.
*P<0.05, significantly different from control group
Table 4. Radiography Findings of Study Groups
Chest X-ray finding  M. pneumoniae group (n=12) Control group (n=42)
Focal reticulonodular  5 (41.7%) 12 (28.6%)
PHPBO 6 (50.0%) 28 (66.7%)
Consolidation 7 (58.3%) 5 (11.9%)
Diffuse interstitial 1 (8.3%) 4 (9.5%)
Atelectasis 1 (8.3%) 1 (2.4%)
Hilar lymphadenopathy 0 (0%) 0 (0%)
Pleural effusion 4 (33.3%) 1 (2.4%)
Normal 0 (0%) 4 (9.5%)
Abbrevations: PHPBO, parahilar peribronchilal opacification.
Fig. 1. Posteroanterior chest radiograph shows dense consolidation of 
the lower right lung zone accompanied by pleural effusion. 
Fig. 2. Posteroanterior chest radiograph shows bilateral parahilar 
peribronchial opacifications, which are more prominent in the right than 
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with KD and 37 febrile controls for superantigen-producing bacteria; 
they identified superantigen-producing organisms in 56% of the 
patients with KD and 35% of the controls. Also, Baker et al.
20) found 
that nonspecific symptoms such as vomiting, diarrhea, abdominal 
pain and cough occur commonly in 10 days before the diagnosis of 
KD. These nonspecific symptoms may reflect diffuse vasculitis or be 
the sequelae of an infectious trigger of KD. Although less likely, we 
cannot exclude the possibility that associated symptoms result from 
concurrent infections unrelated to KD. Within the study of Benseler 
et al.
21), 64% of the patients with KD had been diagnosed with a pre-
sumptive infection before KD; most commonly tonsillitis, viral illness, 
pneumonia, urinary tract infection, gastroenteritis and/or sepsis. 
As mentioned above, the etiology of KD is unknown. However, 
many findings support the notion that infections may play a part. 
Also, nonspecific symptoms occur commonly in KD, which make 
it difficult for clinicians to diagnose KD. Recently specific infections 
are being reported in KD patients such as Chlamydia pneumoniae
22), 
M. pneumonia
23, 24), Staphylococcus aureus
25), Streptococcus
26), 
Yersinia pseudotuberculosis
8), and measles virus
9). Based on these 
reported cases, Abe et al.
27) suggested that the process of superantigens 
activating T cell may be important in the pathophysiology of KD. By 
interacting directly with class two major histocompatability complex 
molecules, superantigens can stimulate polyclonal T cell activation 
with subsequent massive cytokine release. 
Mycoplasma arthritidis is known to produce superantigen
28) 
and it is therefore possible that other Mycoplasma organisms may 
do likewise. Therefore, it is crucial to closely observe nonspecific 
symptoms in KD and look for concurrent infections. M. pneumoniae 
is a major cause of respiratory infections in school-aged children and 
young adults. The most common manifestations include sore throat, 
hoarseness, fever, cough, headache, chills, coryza and myalgia
23). 
Chest auscultation may detect rales, scattered or localized rhonchi 
and expiratory wheezes. Radiographic findings in M. pneumoniae 
group can be extremely variable and mimic a wide variety of lung 
diseases. The diagnosis of Mycoplasma pneumonia is made based 
on clinical manifestations, culture of sputum, cold agglutinins and 
antibody titer of M. pneumoniae specific IgM. In children, a single 
positive IgM assay may be considered diagnostic in most cases, as 
IgM titer typically rises within 7-10 days of infection and appears 
approximately 2 weeks before IgG
24, 29, 30). 
Several manifestations of broncho-pulmonary involvement in 
KD have been described in patients who initially showed prolonged 
fever, lung parenchymal consolidation and laboratory findings of 
pneumonia, presented a clinical picture ascribed to KD
10-17). 
Our previous study reported that abnormal chest X-ray findings 
were noted in 51.2%. Peribronchial cuffing was the most frequent 
abnormality (22.4%)
17).
In our present study, 15% of KD patients had pneumonia con-
currently. The incidence of pulmonary involvement in KD was 
similar to that in other studies
16). Among the patients, 22.2% were 
found to be infected by M. pneumoniae, as confirmed by high 
AMA titer (>1:640). The M. pneumoniae group was not statistically 
different from the control group in the duration of fever, Hb, WBC, 
platelet, ESR, CRP, albumin levels and the incidence of coronary 
arterial lesions. The M. pneumoniae group showed significantly 
higher PMNs and lower lymphocyte count than the control 
group. Among various X-ray findings in the pneumonia patients, 
consolidation and pleural effusion were more frequent in the M. 
pneumoniae group. On the other hand, parahilar peribronchial 
opacification, diffuse interstitial lesion and normal findings were 
prevalent in the control group. 
However, there was no significant difference in the incidence of 
coronary aneurysm in our study. Umezawa et al.
16) reported that 
chest radiographic abnormalities were present in about 15% of 
Kawasaki patients as reticulo-granular opacities (90%), peribronchial 
cuffing (21%), atelectasis (10%) and air trapping (5%), all of which 
were observed within 10 days after the onset of KD; no case of lung 
parenchymal consolidation was mentioned . Kim et al.
17) published 
that peribronchial cuffing (22.4%), reticular pattern (17.7%) and 
hyperaeration (8.2%) were noted in KD patients.  
Lung involvement in KD might be a consequence of vessel in-
flam  mation with increased vascular permeability and perivascular 
edematous changes. Histologic and immunohistochemical studies 
might suggest an underlying association between KD and primary 
respiratory involvement
10). 
A delay in KD diagnosis is more likely to occur in case of incom-
Fig. 3. Posteroanterior chest radiograph shows focal consolidation of 
the right upper lung zone and bilateral reticular densities throughout the 
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plete KD. It is imperative to make efforts to reduce the lag between 
the onset of symptoms and the initiation of treatment. 
The limitation of this study was that the size of the study pop-
ulation was relatively small. Therefore, further large-scaled studies will 
be needed in order to firmly establish the relationship between simple 
M. pneumoniae infection and KD. 
In conclusion, we found that KD patients may have concurrent 
infections especially with pulmonary involvement, and a higher 
incidence of M. pneumoniae infection among the pulmonary 
infection. It is important not to delay treatment of M. pneumoniae 
infection in KD patients and vice versa. 
References
  1)  Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid in
-
volvement with specific desquamation of the fingers and toes in children. 
Arerugi 1967;16:178-222.
 2)  Melish ME, Hicks RM, Larson EJ. Mucocutaneous lymph node 
syndrome in the United States. Am J Dis Child 1976;130:599-607.
 3)  Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new 
infantile acute febrile mucocutaneous lymphnode syndrome (MLNS) 
prevailing in Japan. Pediatrics 1974;54:271-6.
 4)  Fulton DR, Newberger JW. Long-term cardiac sequelae of Kawasaki 
disease. Curr Rheumatol Rep 2000;2:324-9.
 5)  Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, et al. Long-
term consequences of Kawasaki disease. A 10- to 21-year follow-up study 
of 594 patients. Circulation 1996;94:1379-85. 
 6)  Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns 
JC, et al. Diagnosis, treatment, and long-term management of Kawasaki 
disease: a statement for health professionals from the Committee on 
Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on 
Cardiovascular Disease in the Young, American Heart Association. 
Circulation 2004;110:2747-71.
 7)  Barton M, Melbourne R, Morais P, Christie C. Kawasaki Syndrome 
associated with gruop A streptococcal and Epstein-Barr virus co-
infections. Ann Trop Paediatr 2002;22:257-60.
 8)  Konishi N, Baba K, Abe J, Maruko T, Waki K, Takeda N, et al. A case of 
Kawasaki disease with coronary artery aneurysms documenting Yersinia 
pseudotuberculosis infection. Acta Paediatr 1997;86:661-4.
 9)  Kuijpers TW, Herweijer TJ, Schölvinck L, Wertheim-Van Dillen PM, 
Van De Veer EM. Kawasaki disease associated with measles virus 
infection in a monozygotic twin. Pediatr Infect Dis J 2000;19:350-3.
10)  de Maddi F, Cinelli R, Rigante D, Mazzarella G, Siani P. Lung paren-
chymal consolidation as an uncommon presentation and cause of delayed 
diagnosis in atypical Kawasaki syndrome. Rheumatol Int 2009;29:1373-6.
 11)  Uziel Y, Hashkes PJ, Kassem E, Gottesman G, Wolach B. “Unresolving 
pneumonia” as the main manifestation of atypical Kawasaki disease. Arch 
Dis Child  2003;88:940-2.
  12)    Voynow JA, Schanberg L, Sporn T, Kredich D. Pulmonary complications 
associated with Kawasaki disease. J Pediatr 2002;140:786-7. 
13)  Freeman AF, Crawford SE, Finn LS, López-Andreu JA, Ferrando-
Monleón S, Pérez-Tamarit D, et al. Inflammatory pulmonary nodules in 
Kawasaki disease. Pediatr Pulmonol 2003;36:102-6.
14)  Kobayashi Y, Koike Y, Tokutomi T, Kuroki Y, Todoroki I. Case 2: fever, 
rash and pulmonary involvement. diagnosis: Kawasaki disease. Acta 
Paediatr 2006;95:1145-8. 
15)  Sengler C, Gaedicke G, Wahn U, Keitzer R. Pulmonary symptoms in 
Kawasaki disease. Pediatr Infect Dis J 2004;23:782-4.
16)  Umezawa T, Saji T, Matsuo N, Odagiri K . Chest X-ray findings in the 
acute phase of Kawasaki disease. Pediatr Radiol 1989;20:48-51. 
17)  Kim JY, Kwon JH, Kim KH, Yu JH, Hong YM. Chest X-ray findings and 
serum tumor necrosis factor-α levels in patients with Kawasaki disease. 
Korean J Pediatr 2005;48:534-8.
18)  Research Committee on Kawasaki Disease. Report of Subcommittee on 
Standardization of Diagnostic Criteria and Reporting of Coronary Artery 
Lesions in Kawasaki Disease. Tokyo, Japan: Japanese Ministry of Health 
and Welfare, 1984.
19)  Leung DY, Meissner HC, Shulman ST, Mason WH, Gerber MA, Glode 
MP, et al. Prevalence of superantigen-secreting bacteria in patients with 
Kawasaki disease. J Pediatr 2002;140:742-6.
20)  Baker AL, Lu M, Minich LL, Atz AM, Klein GL, Korsin R, et al. Asso-
ciated symptoms in the ten days before diagnosis of Kawasaki disease. J 
Pediatr 2009;154:592-5. 
21)  Benseler SM, McCrindle BW, Silverman ED, Tyrrell PN, Wong J, Yeung 
RS. Infections and Kawasaki disease: implications for coronary artery 
outcome. Pediatrics 2005;116:e760-6.
22) Chua PK, Nerurkar VR, Yu Q, Woodward CL, Melish ME, Yanagihara R, 
et al. Lack of association between Kawasaki syndrome and infection with 
parvovirus B19, human herpesvirus 8, TT virus, GB virus C/hepa  titis G 
virus or Chlamydia pneumoniae. Pediatr Infect Dis J 2000;19:477-9.
23)  Talkington DF, Waites KB, Schwartz SB, Besser RE. Emerging from 
obscurity: understanding pulmonary and extrapulmonary syndromes, 
pathogenesis and epidemiology of human Mycoplasma pneumoniae 
infections. In: Scheld WM, Craig WA, Hughes JM, editors. Emerging 
infections 5. Washington, DC: American Society for Microbiology , 
2001:57-84.
24)  Ferwerda A, Moll HA, de Groot R. Respiratory tract infections by Myco-
plasma pneumoniae in children: a review of diagnostic and therapeutic 
measures. Eur J Pediatr 2001;160:483-91.
25)  Hall M, Hoyt L, Ferrieri P, Schlievert PM, Jenson HB. Kawasaki 
syndrome-like illness associated with infection caused by enterotoxin 
B-secreting Staphylococcus aureus. Clin Infect Dis 1999;29:586-9.
26)  Morita A, Imada Y, Igarashi H, Yutsudo T. Serologic evidence that 
streptococcal superantigens are not involved in the pathogenesis of Kawa-
saki disease. Microbiol Immunol 1997;41:895-900.
27)  Abe J, Kotzin BL, Meissner C, Melish ME, Takahashi M, Fulton D, et al. 
Characterization of T cell repertoire changes in acute Kawasaki disease. J 
Exp Med 1993;177:791-6.
28)  Cole BC. The immunobiology of mycoplasma arthritidis and its super-
antigen MAM. Curr Top Microbiol Immunol 1991;174:107-19.
29)  Waites KB, Rikihisa Y, Taylor-Robinson D. Mycoplasma and Urea-
plasma. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken 
YH, editors. Manual of clinical microbiology. 7th ed. Washington, DC: 
American Society for Microbiology, 1999:782-94.
30)  Waites KB. New concepts of Mycoplasma pneumoniae infections in 
children. Pediatr Pulmonol 2003;36:267-78.